![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZSCAN16 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZSCAN16 mRNA | CTD | PMID:30165855 | ZSCAN16 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of ZSCAN16 mRNA | CTD | PMID:29704546 | ZSCAN16 | Human | acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of ZSCAN16 mRNA | CTD | PMID:11906190 | ZSCAN16 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of ZSCAN16 mRNA | CTD | PMID:22378314 | ZSCAN16 | Human | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of ZSCAN16 mRNA | CTD | PMID:31016361 | ZSCAN16 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZSCAN16 promoter | CTD | PMID:27901495 | ZSCAN16 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZSCAN16 mRNA | CTD | PMID:19549813 | ZSCAN16 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ZSCAN16 mRNA | CTD | PMID:25562108 | ZSCAN16 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of ZSCAN16 mRNA | CTD | PMID:28302478 | ZSCAN16 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN16 mRNA | CTD | PMID:27188386 | ZSCAN16 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of ZSCAN16 mRNA | CTD | PMID:23649840 | ZSCAN16 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of ZSCAN16 mRNA | CTD | PMID:23649840 | ZSCAN16 | Human | geraniol | increases expression | EXP | | 6480464 | geraniol results in increased expression of ZSCAN16 mRNA | CTD | PMID:27683099 | ZSCAN16 | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of ZSCAN16 mRNA | CTD | PMID:35984750 | ZSCAN16 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of ZSCAN16 mRNA | CTD | PMID:28903495 | ZSCAN16 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of ZSCAN16 mRNA | CTD | PMID:28988120 | ZSCAN16 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of ZSCAN16 mRNA | CTD | PMID:23649840 | ZSCAN16 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZSCAN16 mRNA | CTD | PMID:28001369 | ZSCAN16 | Human | niclosamide | decreases expression | EXP | | 6480464 | Niclosamide results in decreased expression of ZSCAN16 mRNA | CTD | PMID:36318118 | ZSCAN16 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN16 mRNA | CTD | PMID:27188386 | ZSCAN16 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ZSCAN16 mRNA | CTD | PMID:31758290 | ZSCAN16 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of ZSCAN16 mRNA | CTD | PMID:24935251 and PMID:26272509 | ZSCAN16 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of ZSCAN16 mRNA | CTD | PMID:28542535 | ZSCAN16 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN16 mRNA | CTD | PMID:27188386 | ZSCAN16 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of ZSCAN16 mRNA | CTD | PMID:37042841 | ZSCAN16 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZSCAN16 mRNA | CTD | PMID:28818685 | ZSCAN16 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ZSCAN16 mRNA | CTD | PMID:29154799 | ZSCAN16 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZSCAN16 mRNA | CTD | PMID:28001369 | ZSCAN16 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of ZSCAN16 mRNA | CTD | PMID:27188386 | |